Comparison Chart Regeneron Pharmaceuticals, Inc.

REGN

US75886F1075

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	REGENERON PHARMACEUTICALS, INC.	Biopharmaceuticals	-0.30%	+9.09%	-1.75%	+32.69%	+30.54%	75.81B

Real-time Estimate Cboe BZX Other stock markets 10:22:32 2026-08-04 EDT			5-day change	1st Jan Change
757.10 ^USD	-0.28%		+9.09%	-1.75%

07-31	Regeneron Pharmaceuticals' Robust Q2 Sales Amid Limited Spend Increases to Help Ramp H2 Margins, RBC Says	MT
07-31	RBC Raises Price Target on Regeneron Pharmaceuticals to $737 From $696, Keeps Sector Perform Rating	MT

Comparison Chart Regeneron Pharmaceuticals, Inc.

Stocks

REGN

US75886F1075

Pharmaceuticals

Compared values